Market Research Logo

Germany Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Momentum has been building behind German Chancellor Angela Merkel's Christian Democrats(CDU), which are set to win a plurality of seats at the federal election on September 24 2017. With regardsto the pharmaceutical sector, while our core view is for another term for Merkel, regardless of who wins theelection, the German government will remain focused on controlling pharmaceutical expenditure.

Headline Expenditure Projections

Pharmaceuticals: EUR55.84bn (USD61.78bn) in 2016 to EUR56.83bn (USD62.51bn) in 2017; +1.8%in local currency terms and +1.2% in US dollar terms.

Healthcare: EUR349.45bn (USD386.63bn) in 2016 to EUR360.26bn (USD396.29bn) in 2017; +3.1% inlocal currency terms and +2.5% in US dollar terms.

Latest Updates

In September, the German capital of Berlin will host a conference on adolescent medicine and childpsychology, in recognition of the importance of the connection between the two.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Germany 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Germany 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Germany 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Germany 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Germany 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Germany 2013-2021)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Germany 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Germany 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Germany 2015-2021)
Pharmaceuticals Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Germany 2011-2016)
Table: Healthcare Personnel (Germany 2011-2016)
Table: Healthcare Activity (Germany 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Bayer Health Care
Boehringer Ingelheim
GlaxoSmithKline (GSK)
Merck KGaA
Pfizer
STADA Arzneimittel
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Germany 1990-2025)
Table: Key Population Ratios (Germany 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Germany 1990-2025)
Table: Population By Age Group (Germany 1990-2025)
Table: Population By Age Group % (Germany 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report